SCHEMBL67175

SCHEMBL67175

Fc1ccc(CN[C@H]2CC[C@@H]3CN(Cc4cccc(C(F)(F)F)c4)C[C@@H]32)cc1

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CACNA1B Q00975 3/20 0.58
KCNH2 Q12809 2/20 0.58
BCHE P06276 4/20 0.46
ACHE P22303 4/20 0.46
BACE1 P56817 4/20 0.46
ALDH1A1 P00352 2/20 0.46
TACR1 P25103 2/20 0.46
CARM1 Q86X55 2/20 0.45
PRMT6 Q96LA8 2/20 0.45
KDM4E B2RXH2 1/20 0.44
GAA P10253 1/20 0.44
CCR3 P51677 1/20 0.43
S1PR1 P21453 1/20 0.43
GRK5 P34947 1/20 0.43
CDK8 P49336 1/20 0.43
S1PR5 Q9H228 1/20 0.43
TEAD1 P28347 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL65388 0.80 CACNA1B (0.71) CACNA1BKCNH2ALDH1A1TACR1S1PR1
SCHEMBL66584 0.80 CACNA1B (0.71) CACNA1BKCNH2ALDH1A1TACR1S1PR1
SCHEMBL65387 0.80 CACNA1B (0.71) CACNA1BKCNH2ALDH1A1TACR1S1PR1
SCHEMBL66912 0.79 CACNA1B (0.59) CACNA1BGAA
SCHEMBL67936 0.79 CACNA1B (0.59) CACNA1BGAA
SCHEMBL16498033 0.79 CACNA1B (0.59) CACNA1BGAA
SCHEMBL66081 0.79 CACNA1B (0.64) CACNA1BKCNH2ALDH1A1TACR1S1PR1
SCHEMBL66527 0.79 CACNA1B (0.64) CACNA1BKCNH2ALDH1A1TACR1S1PR1
SCHEMBL66363 0.79 CACNA1B (0.66) CACNA1BKCNH2ALDH1A1TACR1S1PR1
SCHEMBL66080 0.79 CACNA1B (0.64) CACNA1BKCNH2ALDH1A1TACR1S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8129417-B2 Substituted octahydrocyclopenta[C]pyrrol-4-amines as calcium channel blockers ABBOTT LABORATORIES (US) 2012-03-06 US claimed
WO-2011149995-A1 NOVEL SUBSTITUTED OCTAHYDROCYCLOPENTA [C]PYRROL-4-AMINES AS CALCIUM CHANNEL BLOCKERS ABBOTT LABORATORIES (US) 2011-12-01 WO claimed
US-20110281870-A1 NOVEL SUBSTITUTED OCTAHYDROCYCLOPENTA[C]PYRROL-4-AMINES AS CALCIUM CHANNEL BLOCKERS ABBOTT LABORATORIES (US) 2011-11-17 US claimed
US-20100130558-A1 NOVEL SUBSTITUTED OCTAHYDROCYCLOPENTA[C]PYRROL-4-AMINES AS CALCIUM CHANNEL BLOCKERS ABBOTT LABORATORIES (US) 2010-05-27 US claimed
US-8129417-B2 Substituted octahydrocyclopenta[C]pyrrol-4-amines as calcium channel blockers ABBOTT LABORATORIES (US) 2012-03-06 US disclosed
US-20110281870-A1 NOVEL SUBSTITUTED OCTAHYDROCYCLOPENTA[C]PYRROL-4-AMINES AS CALCIUM CHANNEL BLOCKERS ABBOTT LABORATORIES (US) 2011-11-17 US disclosed
US-20100130558-A1 NOVEL SUBSTITUTED OCTAHYDROCYCLOPENTA[C]PYRROL-4-AMINES AS CALCIUM CHANNEL BLOCKERS ABBOTT LABORATORIES (US) 2010-05-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100130558-A1 NOVEL SUBSTITUTED OCTAHYDROCYCLOPENTA[C]PYRROL-4-AMINES AS CALCIUM CHANNEL BLOCKERS CACNA1C, ORAI1, CACNA1S CACNA1B 5/4885KCNH2 24/4885BCHE 1530/4885
US-20110281870-A1 NOVEL SUBSTITUTED OCTAHYDROCYCLOPENTA[C]PYRROL-4-AMINES AS CALCIUM CHANNEL BLOCKERS CACNA1C, ORAI1, CACNA1S CACNA1B 5/4885KCNH2 24/4885BCHE 1530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.